• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤衍生的 CSF2/粒细胞巨噬细胞集落刺激因子控制髓样细胞的积累和胶质瘤的进展。

Tumour-derived CSF2/granulocyte macrophage colony stimulating factor controls myeloid cell accumulation and progression of gliomas.

机构信息

Laboratory of Molecular Neurobiology, Nencki Institute of Experimental Biology, Warsaw, Poland.

Max Delbruck Center, Molecular Neurosciences, Berlin-Buch, Germany.

出版信息

Br J Cancer. 2020 Aug;123(3):438-448. doi: 10.1038/s41416-020-0862-2. Epub 2020 May 11.

DOI:10.1038/s41416-020-0862-2
PMID:32390004
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7403321/
Abstract

BACKGROUND

Malignant tumours release factors, which attract myeloid cells and induce their polarisation to pro-invasive, immunosuppressive phenotypes. Brain-resident microglia and peripheral macrophages accumulate in the tumour microenvironment of glioblastoma (GBM) and induce immunosuppression fostering tumour progression. Macrophage colony stimulating factors (CSFs) control the recruitment of myeloid cells during peripheral cancer progression, but it is disputable, which CSFs drive their accumulation in gliomas.

METHODS

The expression of CSF2 (encoding granulocyte-macrophage colony stimulating factor) was determined in TCGA datasets and five human glioma cell lines. Effects of stable CSF2 knockdown in glioma cells or neutralising CSF2 or receptor CSF2Rα antibodies on glioma invasion were tested in vitro and in vivo.

RESULTS

CSF2 knockdown or blockade of its signalling reduced microglia-dependent glioma invasion in microglia-glioma co-cultures. CSF2-deficient human glioma cells encapsulated in cell-impermeable hollow fibres and transplanted to mouse brains, failed to attract microglia, but stimulated astrocyte recruitment. CSF2-depleted gliomas were smaller, attracted less microglia and macrophages, and provided survival benefit in tumour-bearing mice. Apoptotic microglia/macrophages were detected in CSF2-depleted tumours.

CONCLUSIONS

CSF2 is overexpressed in a subset of mesenchymal GBMs in association with high immune gene expression. Tumour-derived CSF2 attracts, supports survival and induces pro-tumorigenic polarisation of microglia and macrophages.

摘要

背景

恶性肿瘤释放的因子会吸引髓系细胞,并诱导其向促侵袭、免疫抑制表型极化。脑内小胶质细胞和外周巨噬细胞在胶质母细胞瘤(GBM)的肿瘤微环境中积聚,并诱导免疫抑制,促进肿瘤进展。巨噬细胞集落刺激因子(CSFs)控制着外周癌细胞进展过程中髓系细胞的募集,但哪种 CSF 驱动其在神经胶质瘤中的积累仍存在争议。

方法

在 TCGA 数据集和 5 个人类神经胶质瘤细胞系中测定 CSF2(编码粒细胞-巨噬细胞集落刺激因子)的表达。在体外和体内测试稳定敲低神经胶质瘤细胞中的 CSF2 或中和 CSF2 或受体 CSF2Rα 抗体对神经胶质瘤侵袭的影响。

结果

CSF2 敲低或阻断其信号通路可减少小胶质细胞依赖性神经胶质瘤在小胶质细胞-神经胶质瘤共培养物中的侵袭。包封在细胞不可渗透的中空纤维中的 CSF2 缺陷型人神经胶质瘤细胞移植到小鼠大脑中,无法吸引小胶质细胞,但刺激星形胶质细胞募集。CSF2 耗竭的神经胶质瘤体积较小,吸引的小胶质细胞和巨噬细胞较少,并为荷瘤小鼠提供生存获益。在 CSF2 耗竭的肿瘤中检测到凋亡的小胶质细胞/巨噬细胞。

结论

CSF2 在与高免疫基因表达相关的间充质 GBM 的亚群中过度表达。肿瘤衍生的 CSF2 吸引、支持存活并诱导小胶质细胞和巨噬细胞的促肿瘤发生极化。

相似文献

1
Tumour-derived CSF2/granulocyte macrophage colony stimulating factor controls myeloid cell accumulation and progression of gliomas.肿瘤衍生的 CSF2/粒细胞巨噬细胞集落刺激因子控制髓样细胞的积累和胶质瘤的进展。
Br J Cancer. 2020 Aug;123(3):438-448. doi: 10.1038/s41416-020-0862-2. Epub 2020 May 11.
2
Distinct roles of CSF family cytokines in macrophage infiltration and activation in glioma progression and injury response.脑脊液家族细胞因子在胶质瘤进展和损伤反应中对巨噬细胞浸润和激活的不同作用。
J Pathol. 2013 Jul;230(3):310-21. doi: 10.1002/path.4192.
3
Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas.M2抗炎巨噬细胞表型可能参与人类胶质瘤的生长。
J Pathol. 2008 Sep;216(1):15-24. doi: 10.1002/path.2370.
4
Myeloid-derived suppressor cells promote epithelial ovarian cancer cell stemness by inducing the CSF2/p-STAT3 signalling pathway.髓源性抑制细胞通过诱导 CSF2/p-STAT3 信号通路促进卵巢癌细胞干性。
FEBS J. 2020 Dec;287(23):5218-5235. doi: 10.1111/febs.15311. Epub 2020 Apr 17.
5
Expression of granulocyte colony stimulating factor and granulocyte-macrophage colony stimulating factor genes in human astrocytoma cell lines and in glioma specimens.粒细胞集落刺激因子和粒细胞-巨噬细胞集落刺激因子基因在人星形细胞瘤细胞系及胶质瘤标本中的表达
Brain Res. 1992 Jan 31;571(1):19-25. doi: 10.1016/0006-8993(92)90505-4.
6
Granulocyte-macrophage colony-stimulating factor as an autocrine survival-growth factor in human gliomas.粒细胞-巨噬细胞集落刺激因子作为人神经胶质瘤的自分泌生存生长因子。
Cytokine. 2012 Mar;57(3):347-59. doi: 10.1016/j.cyto.2011.11.016. Epub 2011 Dec 24.
7
Elevated Na/H exchanger 1 (SLC9A1) emerges as a marker for tumorigenesis and prognosis in gliomas.上调的 Na/H 交换蛋白 1(SLC9A1)成为胶质瘤发生和预后的标志物。
J Exp Clin Cancer Res. 2018 Oct 17;37(1):255. doi: 10.1186/s13046-018-0923-z.
8
Characteristics of the alternative phenotype of microglia/macrophages and its modulation in experimental gliomas.小胶质细胞/巨噬细胞的替代表型的特征及其在实验性脑肿瘤中的调节。
PLoS One. 2011;6(8):e23902. doi: 10.1371/journal.pone.0023902. Epub 2011 Aug 25.
9
GM-CSF promotes the immunosuppressive activity of glioma-infiltrating myeloid cells through interleukin-4 receptor-α.GM-CSF 通过白细胞介素-4 受体-α促进胶质瘤浸润髓系细胞的免疫抑制活性。
Cancer Res. 2013 Nov 1;73(21):6413-23. doi: 10.1158/0008-5472.CAN-12-4124. Epub 2013 Sep 12.
10
Decrease of VEGF-A in myeloid cells attenuates glioma progression and prolongs survival in an experimental glioma model.髓样细胞中VEGF - A的减少可减弱实验性胶质瘤模型中的胶质瘤进展并延长生存期。
Neuro Oncol. 2016 Jul;18(7):939-49. doi: 10.1093/neuonc/now005. Epub 2016 Mar 6.

引用本文的文献

1
Evidence for a JAK2/STAT3 proinflammatory and vasculogenic mimicry interrelated molecular signature in adipocyte-derived mesenchymal stromal/stem cells.脂肪细胞来源的间充质基质/干细胞中JAK2/STAT3促炎和血管生成拟态相关分子特征的证据。
Cell Commun Signal. 2025 Jun 19;23(1):291. doi: 10.1186/s12964-025-02298-6.
2
Exploring Therapeutic Targets for Age-Related Macular Degeneration From Circulating Proteins to Plasma Metabolites in the European Population.在欧洲人群中探索年龄相关性黄斑变性的治疗靶点:从循环蛋白到血浆代谢物
Transl Vis Sci Technol. 2025 May 1;14(5):8. doi: 10.1167/tvst.14.5.8.
3
CSF2 promotes chemoresistance in colorectal cancer by regulating Notch pathway.

本文引用的文献

1
Single-cell RNA sequencing reveals functional heterogeneity of glioma-associated brain macrophages.单细胞 RNA 测序揭示了胶质瘤相关脑巨噬细胞的功能异质性。
Nat Commun. 2021 Feb 19;12(1):1151. doi: 10.1038/s41467-021-21407-w.
2
In Search for Reliable Markers of Glioma-Induced Polarization of Microglia.寻找胶质瘤诱导的小胶质细胞极化的可靠标志物。
Front Immunol. 2018 Jun 15;9:1329. doi: 10.3389/fimmu.2018.01329. eCollection 2018.
3
Single-cell profiling of human gliomas reveals macrophage ontogeny as a basis for regional differences in macrophage activation in the tumor microenvironment.
CSF2通过调节Notch信号通路促进结直肠癌的化疗耐药性。
Discov Oncol. 2025 Apr 9;16(1):495. doi: 10.1007/s12672-025-02285-w.
4
Molecular biology of the deadliest cancer - glioblastoma: what do we know?最致命的癌症——胶质母细胞瘤的分子生物学:我们了解多少?
Front Immunol. 2025 Mar 21;16:1530305. doi: 10.3389/fimmu.2025.1530305. eCollection 2025.
5
Microglia in Glioma.胶质瘤中的小胶质细胞。
Adv Neurobiol. 2024;37:513-527. doi: 10.1007/978-3-031-55529-9_28.
6
Phagocytosis Checkpoints in Glioblastoma: CD47 and Beyond.胶质母细胞瘤中的吞噬作用检查点:CD47及其他。
Curr Issues Mol Biol. 2024 Jul 23;46(8):7795-7811. doi: 10.3390/cimb46080462.
7
Insights of immune cell heterogeneity, tumor-initiated subtype transformation, drug resistance, treatment and detecting technologies in glioma microenvironment.胶质瘤微环境中免疫细胞异质性、肿瘤起始亚型转化、耐药性、治疗及检测技术的见解
J Adv Res. 2025 Jun;72:527-554. doi: 10.1016/j.jare.2024.07.033. Epub 2024 Aug 5.
8
Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives.了解胶质瘤的免疫抑制微环境:机制见解和临床观点。
J Hematol Oncol. 2024 May 8;17(1):31. doi: 10.1186/s13045-024-01544-7.
9
Potential diagnostic and drug target markers in glioblastoma.胶质母细胞瘤的潜在诊断和药物靶点标志物。
Sci Rep. 2024 Mar 27;14(1):7292. doi: 10.1038/s41598-024-57752-1.
10
Identification of a novel glioblastoma multiforme molecular subtype with poor prognosis and high immune infiltration based on oxidative stress-related genes.基于氧化应激相关基因鉴定具有不良预后和高免疫浸润的新型胶质母细胞瘤多形性分子亚型。
Medicine (Baltimore). 2024 Feb 16;103(7):e35828. doi: 10.1097/MD.0000000000035828.
单细胞分析人类脑胶质瘤揭示了巨噬细胞的发生发展是肿瘤微环境中巨噬细胞激活的区域差异的基础。
Genome Biol. 2017 Dec 20;18(1):234. doi: 10.1186/s13059-017-1362-4.
4
Inhibition of colony stimulating factor-1 receptor abrogates microenvironment-mediated therapeutic resistance in gliomas.抑制集落刺激因子-1受体可消除胶质瘤中微环境介导的治疗抗性。
Oncogene. 2017 Oct 26;36(43):6049-6058. doi: 10.1038/onc.2017.261. Epub 2017 Jul 31.
5
Glioblastoma-synthesized G-CSF and GM-CSF contribute to growth and immunosuppression: Potential therapeutic benefit from dapsone, fenofibrate, and ribavirin.胶质母细胞瘤合成的粒细胞集落刺激因子和粒细胞-巨噬细胞集落刺激因子有助于肿瘤生长和免疫抑制:氨苯砜、非诺贝特和利巴韦林的潜在治疗益处。
Tumour Biol. 2017 May;39(5):1010428317699797. doi: 10.1177/1010428317699797.
6
Decoupling genetics, lineages, and microenvironment in IDH-mutant gliomas by single-cell RNA-seq.通过单细胞RNA测序解析IDH突变型胶质瘤中的遗传学、谱系和微环境
Science. 2017 Mar 31;355(6332). doi: 10.1126/science.aai8478.
7
Immune microenvironment of gliomas.脑胶质瘤的免疫微环境。
Lab Invest. 2017 May;97(5):498-518. doi: 10.1038/labinvest.2017.19. Epub 2017 Mar 13.
8
Stimulatory versus suppressive effects of GM-CSF on tumor progression in multiple cancer types.粒细胞-巨噬细胞集落刺激因子(GM-CSF)对多种癌症类型肿瘤进展的刺激与抑制作用
Exp Mol Med. 2016 Jul 1;48(7):e242. doi: 10.1038/emm.2016.64.
9
The tumor microenvironment underlies acquired resistance to CSF-1R inhibition in gliomas.肿瘤微环境是胶质瘤对CSF-1R抑制产生获得性耐药的基础。
Science. 2016 May 20;352(6288):aad3018. doi: 10.1126/science.aad3018.
10
Tumour-processed osteopontin and lactadherin drive the protumorigenic reprogramming of microglia and glioma progression.肿瘤处理过的骨桥蛋白和乳黏附素驱动了小胶质细胞的促肿瘤重编程和神经胶质瘤的进展。
Oncogene. 2016 Dec 15;35(50):6366-6377. doi: 10.1038/onc.2016.55. Epub 2016 Apr 4.